Home
RVTY
RVTY News

Latest Revvity Inc. (RVTY) News on November 16, 2025

MT Newswires

a month ago

TD Cowen Adjusts Price Target on Revvity to $120 From $126, Maintains Buy Rating

Revvity Showcases Progress with Purpose in 2025 Impact Report

Business Wire

a month ago

Revvity Showcases Progress with Purpose in 2025 Impact Report

Morningstar Research

a month ago

Analyst Report: Revvity, Inc.

MT Newswires

a month ago

Leerink Partners Adjusts Revvity Price Target to $120 From $110, Maintains Outperform Rating

Medpace and Revvity Stocks Trade Down, What You Need To Know

StockStory

a month ago

Medpace and Revvity Stocks Trade Down, What You Need To Know

RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes

Zacks

a month ago

RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes

1 Profitable Stock to Own for Decades and 2 We Turn Down

StockStory

a month ago

1 Profitable Stock to Own for Decades and 2 We Turn Down

MT Newswires

a month ago

Barclays Adjusts Price Target on Revvity to $100 From $110, Maintains Overweight Rating

MT Newswires

a month ago

Revvity Launches Program to Expand Type 1 Diabetes Diagnosis Offering

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

Business Wire

a month ago

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know

StockStory

2 months ago

Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know

MT Newswires

2 months ago

Leerink Partners Adjusts Revvity Price Target to $110 From $115, Maintains Outperform Rating

1 Oversold Stock Primed to Rebound and 2 We Brush Off

StockStory

2 months ago

1 Oversold Stock Primed to Rebound and 2 We Brush Off

Revvity, Inc. (RVTY) Launches its New In Vivo Imaging Center of Excellence

Insider Monkey

2 months ago

Revvity, Inc. (RVTY) Launches its New In Vivo Imaging Center of Excellence

Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know

StockStory

3 months ago

Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know

Revvity price target lowered to $110 from $116 at BofA

TipRanks

5 months ago

Revvity price target lowered to $110 from $116 at BofA

Argus Research

5 months ago

RVTY: Raising target price to $101.00

Is Revvity Stock Underperforming the Dow?

Barchart

5 months ago

Is Revvity Stock Underperforming the Dow?

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 39% Undervalued

Simply Wall St.

5 months ago

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 39% Undervalued

1 Profitable Stock with Exciting Potential and 2 to Be Wary Of

StockStory

5 months ago

1 Profitable Stock with Exciting Potential and 2 to Be Wary Of

Argus Research

5 months ago

RVTY: Raising target price to $101.00

Pediatrix Medical Group (MD) Down 3.1% Since Last Earnings Report: Can It Rebound?

Zacks

5 months ago

Pediatrix Medical Group (MD) Down 3.1% Since Last Earnings Report: Can It Rebound?

3 Healthcare Stocks Skating on Thin Ice

StockStory

5 months ago

3 Healthcare Stocks Skating on Thin Ice

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

Business Wire

5 months ago

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

Does The Market Have A Low Tolerance For Revvity, Inc.'s (NYSE:RVTY) Mixed Fundamentals?

Simply Wall St.

6 months ago

Does The Market Have A Low Tolerance For Revvity, Inc.'s (NYSE:RVTY) Mixed Fundamentals?

RVTY Stock Falls Despite the Latest Launch of Automated Instrument

Zacks

6 months ago

RVTY Stock Falls Despite the Latest Launch of Automated Instrument

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

StockStory

6 months ago

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

Business Wire

6 months ago

Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

3 Mid-Cap Stocks with Questionable Fundamentals

StockStory

6 months ago

3 Mid-Cap Stocks with Questionable Fundamentals

S&P 500 Gains & Losses Today: Supermicro Stock Surges After DataVolt Deal

Investopedia

6 months ago

S&P 500 Gains & Losses Today: Supermicro Stock Surges After DataVolt Deal

Shareholders Will Be Pleased With The Quality of Revvity's (NYSE:RVTY) Earnings

Simply Wall St.

6 months ago

Shareholders Will Be Pleased With The Quality of Revvity's (NYSE:RVTY) Earnings

Argus Research

6 months ago

RVTY: Raising target price to $102.00

Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know

StockStory

6 months ago

Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know

RVTY Q1 Earnings Call: Resilient Performance Amid Academic and Tariff Headwinds, Software and Diagnostics Shine

StockStory

6 months ago

RVTY Q1 Earnings Call: Resilient Performance Amid Academic and Tariff Headwinds, Software and Diagnostics Shine

Argus Research

6 months ago

RVTY: Lowering target price to $95.00

3 S&P 500 Stocks in the Doghouse

StockStory

6 months ago

3 S&P 500 Stocks in the Doghouse

MT Newswires

6 months ago

UBS Upgrades Revvity to Buy from Neutral, Cuts Price Target to $115 From $145

1 Safe-and-Steady Stock with Exciting Potential and 2 to Avoid

StockStory

7 months ago

1 Safe-and-Steady Stock with Exciting Potential and 2 to Avoid

MT Newswires

7 months ago

KeyBanc Adjusts Revvity's Price Target to $135 From $145

Revvity to Present at Upcoming Investor Conferences

Business Wire

7 months ago

Revvity to Present at Upcoming Investor Conferences

Mettler-Toledo (MTD) Q1 Earnings: What To Expect

StockStory

7 months ago

Mettler-Toledo (MTD) Q1 Earnings: What To Expect

Revvity First Quarter 2025 Earnings: EPS Beats Expectations

Simply Wall St.

7 months ago

Revvity First Quarter 2025 Earnings: EPS Beats Expectations

MT Newswires

7 months ago

Baird Adjusts Price Target on Revvity to $125 From $127, Maintains Outperform Rating

MT Newswires

7 months ago

Raymond James Adjusts Price Target on Revvity to $120 From $145, Maintains Outperform Rating

MT Newswires

7 months ago

JPMorgan Adjusts Price Target on Revvity to $100 From $120, Maintains Neutral Rating

MT Newswires

7 months ago

KeyBanc Adjusts Price Target on Revvity to $145 From $135, Maintains Overweight Rating

MT Newswires

7 months ago

TD Cowen Adjusts Price Target on Revvity to $126 From $122, Maintains Buy Rating

MT Newswires

7 months ago

Goldman Sachs Adjusts Price Target on Revvity to $125 From $140, Maintains Buy Rating

Company News for Apr 29, 2025

Zacks

7 months ago

Company News for Apr 29, 2025

MT Newswires

7 months ago

Evercore ISI Adjusts Price Target on Revvity to $116 From $125

Biotech Firm Revvity Reports Better-Than-Expected Earnings

Investopedia

7 months ago

Biotech Firm Revvity Reports Better-Than-Expected Earnings

Revvity (RVTY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

7 months ago

Revvity (RVTY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

MT Newswires

7 months ago

Sector Update: Health Care Stocks Mixed Premarket Monday

MT Newswires

7 months ago

Sector Update: Health Care

Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook

Reuters

7 months ago

Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook

Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates

Zacks

7 months ago

Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates

MT Newswires

7 months ago

Revvity Q1 Adusted Earnings, Revenue Increase; 2025 Revenue Outlook Lifted

Why Revvity (RVTY) Could Beat Earnings Estimates Again

Zacks

7 months ago

Why Revvity (RVTY) Could Beat Earnings Estimates Again

Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely?

Zacks

7 months ago

Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely?

Revvity Board Declares Quarterly Dividend

Business Wire

7 months ago

Revvity Board Declares Quarterly Dividend

Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for

Zacks

7 months ago

Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for

3 Cash-Producing Stocks Skating on Thin Ice

StockStory

7 months ago

3 Cash-Producing Stocks Skating on Thin Ice

Argus Research

7 months ago

RVTY: Lowering target price to $97.00

Earnings Preview: Revvity (RVTY) Q1 Earnings Expected to Decline

Zacks

7 months ago

Earnings Preview: Revvity (RVTY) Q1 Earnings Expected to Decline

MT Newswires

7 months ago

Leerink Partners Adjusts Price Target on Revvity to $135 From $140, Keeps Outperform Rating

MT Newswires

7 months ago

Wells Fargo Adjusts Price Target on Revvity to $102 From $130, Keeps Equalweight Rating

MT Newswires

7 months ago

Bernstein Adjusts Price Target on Revvity to $120 From $140, Maintains Market Perform Rating

Argus Research

7 months ago

RVTY: Raising target price to $100.00

What Is Revvity, Inc.'s (NYSE:RVTY) Share Price Doing?

Simply Wall St.

7 months ago

What Is Revvity, Inc.'s (NYSE:RVTY) Share Price Doing?

MT Newswires

7 months ago

BofA Securities Cuts Price Target on Revvity to $116 From $143, Maintains Buy Rating

MT Newswires

7 months ago

KeyBanc Lowers Price Target on Revvity to $135 From $145

Morningstar Research

7 months ago

Analyst Report: Revvity, Inc.

MT Newswires

7 months ago

Barclays Adjusts Price Target on Revvity to $110 From $140

MT Newswires

7 months ago

KeyBanc Adjusts Price Target on Revvity to $145 From $135, Keeps Overweight Rating

Argus Research

7 months ago

RVTY: Lowering target price to $96.00

Revvity to Hold Earnings Call on Monday, April 28, 2025

Business Wire

7 months ago

Revvity to Hold Earnings Call on Monday, April 28, 2025

FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo

Medical Device Network

7 months ago

FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo

MT Newswires

7 months ago

Evercore ISI Adjusts Revvity Price Target to $125 From $138, Maintains Outperform Rating

MT Newswires

7 months ago

Revvity Says FDA Approves Auto-Pure 2400 Liquid Handler for Tuberculosis Test

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Business Wire

7 months ago

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Zacks

7 months ago

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Argus Research

7 months ago

RVTY: Lowering target price to $110.00

1 Healthcare Stock to Target This Week and 2 to Turn Down

StockStory

8 months ago

1 Healthcare Stock to Target This Week and 2 to Turn Down

Argus Research

8 months ago

RVTY: Lowering target price to $113.00

The total return for Revvity (NYSE:RVTY) investors has risen faster than earnings growth over the last five years

Simply Wall St.

8 months ago

The total return for Revvity (NYSE:RVTY) investors has risen faster than earnings growth over the last five years

Revvity Stock Tumbles Despite Expanding Genomics England Alliance

Zacks

8 months ago

Revvity Stock Tumbles Despite Expanding Genomics England Alliance

Morningstar Research

8 months ago

Analyst Report: Revvity, Inc.

MT Newswires

8 months ago

Revvity Expands Alliance with Genomics England

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

Business Wire

8 months ago

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

MT Newswires

8 months ago

KeyBanc Adjusts Price Target on Revvity to $145 From $135, Maintains Overweight Rating

Revvity's (NYSE:RVTY) Solid Earnings Have Been Accounted For Conservatively

Simply Wall St.

8 months ago

Revvity's (NYSE:RVTY) Solid Earnings Have Been Accounted For Conservatively

Argus Research

8 months ago

RVTY: Lowering target price to $87.00

MT Newswires

8 months ago

Revvity Says Euroimmun Gets CE Mark for Measles Antibody Detection

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Business Wire

8 months ago

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks

StockStory

8 months ago

Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks

Revvity Full Year 2024 Earnings: In Line With Expectations

Simply Wall St.

9 months ago

Revvity Full Year 2024 Earnings: In Line With Expectations

3 Reasons to Sell RVTY and 1 Stock to Buy Instead

StockStory

9 months ago

3 Reasons to Sell RVTY and 1 Stock to Buy Instead

Do Options Traders Know Something About Revvity (RVTY) Stock We Don't?

Zacks

9 months ago

Do Options Traders Know Something About Revvity (RVTY) Stock We Don't?

Argus Research

9 months ago

RVTY: Raising target price to $92.00

MT Newswires

9 months ago

Revvity Wins Permanent Injunction Against Cloud Software Group

Share on Social Networks: